Working… Menu

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of EV-077 in Type 2 Diabetic Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01551381
Recruitment Status : Terminated (Interim review indicated that the dose selected was too high for diabetics)
First Posted : March 12, 2012
Last Update Posted : June 17, 2013
Information provided by (Responsible Party):
Evolva SA

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : May 2012
Actual Study Completion Date : May 2012